These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22245215)

  • 1. Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets.
    Greenblatt MB; Sargent JL; Farina G; Tsang K; Lafyatis R; Glimcher LH; Whitfield ML; Aliprantis AO
    Am J Pathol; 2012 Mar; 180(3):1080-1094. PubMed ID: 22245215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Zhou L; Askew D; Wu C; Gilliam AC
    J Invest Dermatol; 2007 Feb; 127(2):281-92. PubMed ID: 16917493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
    Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
    Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egr-ly awaiting a "personalized medicine" approach to treat scleroderma.
    Leask A
    J Cell Commun Signal; 2012 Jun; 6(2):111-3. PubMed ID: 22350706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?
    Assassi S; Mayes MD
    Curr Opin Rheumatol; 2013 Nov; 25(6):686-91. PubMed ID: 24061076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    J Invest Dermatol; 2012 Dec; 132(12):2752-61. PubMed ID: 22810302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Zhang Y; McCormick LL; Gilliam AC
    J Invest Dermatol; 2003 Oct; 121(4):713-9. PubMed ID: 14632186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma.
    Matsushita M; Yamamoto T; Nishioka K
    Int Arch Allergy Immunol; 2004 Dec; 135(4):348-56. PubMed ID: 15564778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
    Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
    Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.
    Zhang Y; Shen L; Dreißigacker K; Zhu H; Trinh-Minh T; Meng X; Tran-Manh C; Dees C; Matei AE; Chen CW; Ditschkowski M; Krauss S; Winkler J; Wolff D; Ziemer M; Beilhack A; Karrer S; Herr W; Mackensen A; Schett G; Spriewald BM; Distler JHW
    Blood; 2021 Apr; 137(17):2403-2416. PubMed ID: 33529322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.
    Sargent JL; Li Z; Aliprantis AO; Greenblatt M; Lemaire R; Wu MH; Wei J; Taroni J; Harris A; Long KB; Burgwin C; Artlett CM; Blankenhorn EP; Lafyatis R; Varga J; Clark SH; Whitfield ML
    Arthritis Rheumatol; 2016 Aug; 68(8):2003-15. PubMed ID: 26945694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma.
    Ong C; Wong C; Roberts CR; Teh HS; Jirik FR
    Eur J Immunol; 1998 Sep; 28(9):2619-29. PubMed ID: 9754550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.
    Bujor AM; El Adili F; Parvez A; Marden G; Trojanowska M
    Front Immunol; 2020; 11():800. PubMed ID: 32508810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
    Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.
    Du J; Paz K; Flynn R; Vulic A; Robinson TM; Lineburg KE; Alexander KA; Meng J; Roy S; Panoskaltsis-Mortari A; Loschi M; Hill GR; Serody JS; Maillard I; Miklos D; Koreth J; Cutler CS; Antin JH; Ritz J; MacDonald KP; Schacker TW; Luznik L; Blazar BR
    Blood; 2017 May; 129(18):2570-2580. PubMed ID: 28254742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of CCL2/monocyte chemoattractant protein-1 in the pathogenesis of cutaneous sclerosis.
    Yamamoto T
    Clin Exp Rheumatol; 2003; 21(3):369-75. PubMed ID: 12846061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
    J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stretching Reduces Skin Thickness and Improves Subcutaneous Tissue Mobility in a Murine Model of Systemic Sclerosis.
    Xiong Y; Berrueta L; Urso K; Olenich S; Muskaj I; Badger GJ; Aliprantis A; Lafyatis R; Langevin HM
    Front Immunol; 2017; 8():124. PubMed ID: 28261202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.